From: Prognostic value of HLA class I expression in patients with colorectal cancer
Positive | Dull and negative | Total | P value | |
---|---|---|---|---|
( n = 51; 53%) | ( n = 46; 47%) | ( n = 97) | ||
Stage | 0.54 | |||
Stage IIA | 46 (90) | 42 (91) | 88 | |
Stage IIB | 2 (4) | 0 (0) | 2 | |
Stage IIC | 3 (6) | 4 (9) | 7 | |
Age (years) | 0.11 | |||
Mean ± SD | 64 ± 9.7 | 60 ± 12.3 | ||
Range | 42 ~ 80 | 31 ~ 83 | ||
Gender—no. of patients (%) | 0.03 | |||
Male | 27 (53%) | 34 (74%) | 61 | |
Female | 24 (47%) | 12 (26%) | 36 | |
Diameter of primary tumor (mm)—no. (%) | 0.87 | |||
≦30 | 11 (22%) | 12 (26%) | 23 | |
31–50 | 21 (41%) | 17 (37%) | 38 | |
≧51 | 19 (37%) | 17 (37%) | 36 | |
Location—no. of patients (%) | 0.84 | |||
Right | 16 (31%) | 13 (28%) | 29 | |
Left | 15 (30%) | 16 (35%) | 31 | |
Rectum | 20 (39%) | 17 (37%) | 37 | |
Histological type—no. (%) | 0.23 | |||
Well/mod | 48 (94%) | 40 (87%) | 88 | |
Por/muc | 3 (6%) | 6 (13%) | 9 | |
Lymphatic invasion—no. of patients (%) | 0.55 | |||
Negative | 45 (88%) | 40 (87%) | 85 | |
Positive | 6 (12%) | 6 (13%) | 12 | |
Venous invasion—no. of patients (%) | 0.33 | |||
Negative | 44 (86%) | 42 (91%) | 86 | |
Positive | 7 (14%) | 4 (9%) | 11 |